Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects-Reference-Cited by-同舟云学术

Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects

Published:2017-06 Issue: Volume:104 Page:315-325
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Joseph Emil,Reddi Satish,Rinwa Vibhu,Balwani Garima,Saha Ranendra

Funder

University Grants Commission

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference57 articles.

1. An animal model of antipsychotic-induced weight gain;Arjona;Behav. Brain Res.,2004

2. Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion?;Brambilla;Psychoneuroendocrinology,2007

3. Nanoparticle and targeted systems for cancer therapy;Brannon-Peppas;Adv. Drug Deliv. Rev.,2012

4. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements;Buchanan;Schizophr. Bull.,2010

5. Olanzapine;Callaghan;Clin. Pharmacokinet.,1999

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation development, in-vitro and ex-vivo evaluation of dry adsorbed solid lipid nanoparticles: an approach of overcoming olanzapine drawbacks;European Pharmaceutical Journal;2024-04-20

2. Design, Optimization and Evaluation of Intranasal Nanotherapeutic of Atypical Antipsychotic Drug;2023-12-15

3. Clozapine-loaded nanocapsules improve antipsychotic activity in rats: building a sequential PopPK/PD model to discriminate nanocarriers in the preformulation step;Pharmaceutical Research;2023-06-22

4. Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy;Pharmaceutics;2023-02-17

5. Gene Therapy, A Potential Therapeutic Tool for Neurological and Neuropsychiatric Disorders: Applications, Challenges and Future Perspective;Current Gene Therapy;2023-02